In CRC, one of the most commonly inactivated signaling pathways is the transforming growth factor beta (TGF-β) signaling pathway, which has been associated with the establishment and progression of intestinal neoplasms [4]. The gene discussed is TGFB1; the disease is colorectal carcinoma.